Groundbreaking of Evergreen Theragnostic’s radiopharmaceutical manufacturing facility in New Jersey marks milestone project for Bergmann

Bergmann’s newly formed Science, Technology and Industry (STI) practice marked a notable milestone with the groundbreaking of a new manufacturing facility for Evergreen Theragnostics, Inc., a radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) in Springfield, NJ.

This marks the completion of the first project designed by the STI team, involving team members from multiple offices and disciplines across Bergmann. Additionally, the project was on a fast-track timeline, and was designed and delivered at the start of the pandemic with Bergmann’s team working completely remotely.

Bergmann’s services for the new building included the planning, design, and engineering for architectural, interiors, HVAC, plumbing, fire protection, electrical, and lighting.

“Working with companies like Evergreen Theragnostics is tremendous, stated Charlie Johnsrud, Principal and STI leader. “Their entire team, starting with their CEO, James Cook, is passionate about impacting patients’ lives for the better. It’s contagious and makes our work that much more satisfying to know the mission and goal that we’re contributing to.”

Set to open next year, Evergreen will serve the manufacturing needs of companies developing and commercializing radiopharmaceuticals, from preclinical and early stage clinical trials to full scale commercial manufacturing of approved products.